Treatment of stomach cancer is multifaceted, involving a combination of surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and supportive care. The choice of treatment depends on ...

Dear Dr. Roach: Is 18 years a record for living without a stomach? A family member had stomach cancer when he was 70 and had ...

Retlirafusp alfa is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Gastric Cancer.

A global study reveals a disturbing rise in early-onset gastric cancer, a disease once predominantly affecting older adults ...

Xilio Therapeutics is a biotechnology company that discovers and develops immuno-oncology therapeutics for the treatment of lung cancer. Xilio Therapeutics is headquartered in Waltham, Massachusetts, ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

The following is a summary of “Stomach and duodenal ulcer as a cause of death in patients with cancer: a cohort study,” ...